Komen Foundation

The funding from Susan G. Komen will help support the project's effort to  gather genomic and other data from young breast cancer patients.

NEW YORK (GenomeWeb News) – Pathway Genomics and Susan G. Komen today said they are partnering to educate women about screening options available for detecting a genetic predisposition for breast cancer.

NEW YORK (GenomeWeb News) – Scientists at Washington University in St. Louis and the Institute of Cancer Research in London plan to use a $4 million grant from the Susan G.

By Matt Jones
NEW YORK (GenomeWeb News) – Michigan State University has won a $450,000 grant from the Susan G. Komen for the Cure foundation to conduct studies focused on gene expression in breast cancer tumors.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Susan G. Komen for the Cure foundation has granted $3.5 million to a trio of research institutes to study triple-negative breast cancer in African and African-American women.

The team plans to use sequencing to create a polyepitope DNA vaccine that will contain "fragments from each individual mutated protein" for individual patients. They hope to begin human trials for the vaccine within the next two years.

"Identification and validation of mutations in individual breast cancers provides an unprecedented opportunity to target unique tumor antigens with personalized breast cancer vaccines," the researchers wrote in their project abstract.

Despite pleas of breast cancer advocates to maintain access to Avastin using gene markers to identify those most likely to benefit, there is little evidence to suggest that the drug company or regulatory experts are considering this strategy.

The nearly $19 million in funding for PGx research projects is provided through Komen's Promise Grants.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.